Dapagliflozin is an oral antidiabetic medication belonging to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, used alongside diet and exercise to improve glycemic control in adults with type… Read more



Dapagliflozin is an oral antidiabetic medication belonging to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes. By selectively blocking the SGLT2 protein in the kidneys, this drug reduces glucose reabsorption and promotes its excretion through urine, a mechanism that also supports cardiovascular and renal health. Our catalog of Dapagliflozin related compounds provides essential reference standards, including pharmacopeial and non-pharmacopeial impurities, degradation products, positional isomers, and stable isotope labelled compounds. These materials are critical for pharmaceutical laboratories conducting impurity profiling, method validation, and quality control. By using these highly characterized standards, researchers can accurately identify and quantify trace contaminants and degradation pathways during stability studies, ensuring compliance with global regulatory guidelines and maintaining the highest standards of drug safety and therapeutic efficacy.